导电测量生物传感器用于慢性病管理中的尿路生物标志物的快速检测
Sreekanth S P1, Ganganath S Perera1, Shanmuga Sundar Dhanabalan1,2
1Functional Materials and Microsystems Research Group and the Micro Nano Research Facility, RMIT University, Melbourne, VIC 3001, Australia.
ACS applied bio materials
|October 22, 2025
概括
新的导电测量生物传感器可以在尿液中快速和灵敏地检测慢性病 (CKD) 的关键生物标志物. 这些基于高电阻的设备为改善CKD管理和治疗提供了低成本的便携式解决方案.
科学领域:
- 生物医学工程 生物医学工程
- 临床化学 临床化学
- 材料科学 材料科学 材料科学
背景情况:
- 慢性病 (CKD) 是一个具有复杂病理生理学的重大全球健康问题.
- 有效的CKD管理依赖于监测特定的尿液生物标志物,如β-2微球蛋白 (β2MG),表皮生长因子 (EGF) 和CD163.
- 现有的这些生物标志物的检测方法有局限性,包括复杂性,长检测时间和敏感性差.
研究的目的:
- 开发和验证基于高电阻 (HR-Si) 的新型电导度生物传感器.
- 为了快速,灵敏和经济有效地检测尿样中的β2MG,EGF和CD163.
- 克服当前用于CKD管理的生物标志物检测技术的局限性.
主要方法:
- 基于HR-Si的传导度生物传感器的制造.
- 在人类尿样中检测β2MG,EGF和CD163.
- 性能评估包括灵敏度,选择性和检测时间.
主要成果:
- 传导度生物传感器实现了β2MG (100 fM),EGF (5 pM) 和CD163 (10 fM) 的低检测极限.
- 证明了快速检测时间 (<2分钟) 和短样本化时间 (<15分钟).
- 突出了诸如简单,低成本制造,高选择性和小型化潜力等优点.
结论:
- 基于HR-Si的传导度生物传感器代表了对CKD生物标志物检测的有希望的需求点工具.
- 这些生物传感器为现有方法提供了快速,灵敏和成本效益的替代方案.
- 这项技术有可能在慢性病的管理和治疗中发挥重要作用.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
335
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
335
Chronic Kidney Disease I: Introduction
557
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
557
Chronic Kidney Disease IV: Nursing Management
314
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
314
Serum Studies: Renal Function Tests
361
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
361
Nephrotic Syndrome II : Assessment and Medical Management
197
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
197
Chronic Kidney Disease II: Clinical Manifestations
547
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
547


